Paula and Bobby
Parents of Lillie
Mucopolysaccharidosis, Type IIIB
What is Mucopolysaccharidosis, Type IIIB?
It is a subtype of Mucopolysaccharidosis, Type III. There are four subtypes of this form of the syndrome. Known as a form of childhood dementia the syndrome causes brain damage that is eventually fatal.
Type B is the second most common subtype, after Type A. Except in some Southern European countries where it is the most common subtype.
What gene changes cause Mucopolysaccharidosis, Type IIIB?
Changes in the NAGLU gene are responsible for causing the syndrome. It is inherited in an autosomal recessive manner.
Autosomal recessive inheritance means an affected individual receives one copy of a mutated gene from each of their parents, giving them two copies of a mutated gene. Parents, who carry only one copy of the gene mutation will not generally show any symptoms, but have a 25% chance of passing the copies of the gene mutations onto each of their children.
What are the main symptoms of Mucopolysaccharidosis, Type IIIB?
Symptoms of the syndrome do not usually present at birth. One of the first symptoms recognised is developmental delay which is usually identified in early childhood and before the age of 6. From this age the symptoms become more severe, and intellectual ability starts to decline. Behavioral issues, including hyperactivity, are also a major symptom and often one of the first identified. Sleeping issues are also common. Affected individuals will also experience speech delay which gets progressively worse with age.
Physical features of the syndrome include coarse hair, excessive hair growth, coarse facial features, and hearing and vision loss. Enlarged organs such as the liver and/or spleen and hernias are also features of the syndrome.
Life expectancy can be varied, ranting from childhood, to early adolescence or early adulthood
How does someone get tested for Mucopolysaccharidosis, Type IIIB?
The initial testing for Mucopolysaccharidosis, Type IIIB can begin with facial analysis screening, through the FDNA Telehealth telegenetics platform, which can identify the key markers of the syndrome and outline the need for further testing. A consultation with a genetic counselor and then a geneticist will follow.
Based on this clinical consultation with a geneticist, the different options for genetic testing will be shared and consent will be sought for further testing.
What is FDNA Telehealth?
FDNA Telehealth is a leading digital health company that provides faster access to accurate genetic analysis.
With a hospital technology recommended by leading geneticists, our unique platform connects patients with genetic experts to answer their most pressing questions and clarify any concerns they may have about their symptoms.
Benefits of FDNA Telehealth
Our platform is currently used by over 70% of geneticists and has been used to diagnose over 250,000 patients worldwide.
FDNA Telehealth provides facial analysis and screening in minutes, followed by fast access to genetic counselors and geneticists.
Ease of Use
Our seamless process begins with an initial online diagnosis by a genetic counselor and follows by consultations with geneticists and genetic testing.
Accuracy & Precision
Advanced artificial intelligence (AI) capabilities and technology with a 90% accuracy rate for a more accurate genetic analysis.
Faster access to genetic counselors, geneticists, genetic testing, and a diagnosis. As fast as within 24 hours if required. Save time and money.
Privacy & Security
We guarantee the utmost protection of all images and patient information. Your data is always safe, secure, and encrypted.